非布司他治疗痛风性关节炎的疗效及其安全性评价
本文选题:非布司他 切入点:痛风性关节炎 出处:《吉林大学学报(医学版)》2017年01期 论文类型:期刊论文
【摘要】:目的:观察非布司他治疗痛风性关节炎的疗效及治疗前后患者受累关节彩色超声图像的变化。方法:选择66例男性痛风性关节炎患者,根据药物使用情况分为非布司他组(非布司他40 mg·d-1,n=37)和别嘌醇组(别嘌醇100mg·d-1,n=29),观察2组患者治疗前后血尿酸(UA)、血脂水平和滑膜周围血流信号及受累关节的彩色多普勒超声图像的变化。结果:2组患者治疗后血UA水平下降,与治疗前比较差异均有统计学意义(P0.05);在16、20和24周,非布司他组患者达到目标血UA值的百分率均较别嘌醇组高,2组间比较差异有统计学意义(P0.05)。与治疗前比较,治疗后非布司他组患者高密度脂蛋白(HDL)水平明显升高(P=0.001),而总胆固醇(TC)、甘油三酯(TG)及低密度脂蛋白(LDL)水平无明显变化(P0.05);别嘌醇组患者治疗前后TC、HDL、LDL和TG水平均无明显变化(P0.05)。2组患者治疗后大部分痛风结晶消失(非布司他组占71.4%,别嘌醇组占58.9%),非布司他组较别嘌醇组痛风结晶溶解效果更佳。2组患者痛风急性发作期的关节腔积液、关节周围软组织肿胀和滑膜周围血流信号均有改善,但2组之间比较未见明显差别。2组患者痛风慢性发作期表现比较无明显差异。结论:非布司他可更有效地降低痛风性关节炎患者血UA水平,改善痛风急性发作期表现,痛风结晶溶解效果更佳。
[Abstract]:Objective: to observe the therapeutic effect of Festa on gouty arthritis and the changes of color ultrasound images of involved joints before and after treatment. Methods: 66 male patients with gouty arthritis were selected. According to the drug use, the patients were divided into two groups: non-buflast group (40 mg 路d ~ (-1)) and allopurinol group (100 mg 路d ~ (-1)) allopurinol. Before and after treatment, the levels of serum uric acid and UAA, blood lipid level, peripheral blood flow signal and color Doppler flow of the involved joints were observed in both groups. Results the serum UA level decreased after treatment in two groups of patients. There were significant differences between before and after treatment (P 0.05), and at the 20th and 24th weeks after treatment, the percentage of patients in the non-busulta group who reached the target blood UA value was significantly higher than that in the allopurinol group (P 0.05), and was significantly higher than that in the allopurinol group (P 0.05), and was significantly higher than that in the control group (P < 0.05). After treatment, high density lipoprotein (HDL) levels were significantly increased in patients with Festalta group, but the levels of TC, TG, TGG and LDL were not significantly changed (P 0.05), while in allopurinol group there were no significant changes in LDL and TG levels of TCU before and after treatment, and there was no significant change in the levels of TCU HDLLDL and TG in allopurinol group before and after treatment. Most of the gout crystals disappeared after treatment (71.4% in the non-Budesta group, 58.9% in the allopurinol group, better dissolution of gout crystals in the non-Budesta group than in the allopurinol group. The swelling of the soft tissue around the joint and the blood flow signal around the synovium were improved. However, there was no significant difference between the two groups. Conclusion: the blood UA level of patients with gouty arthritis can be reduced more effectively, and the symptoms of gout acute attack can be improved. The effect of gout crystal dissolution is better.
【作者单位】: 吉林大学第一医院风湿免疫科;
【基金】:吉林省科技厅科技发展计划项目资助课题(20150101152JC)
【分类号】:R589.7
【相似文献】
相关期刊论文 前10条
1 荣晓华;痛风方治疗痛风性关节炎32例[J];山东中医杂志;2000年07期
2 房满庭,张安林;上中下通用痛风汤为主治疗痛风性关节炎30例[J];邯郸医学高等专科学校学报;2000年05期
3 张持;中药治疗痛风性关节炎38例[J];天津中医学院学报;2000年01期
4 王建祥;中药内服与外洗治疗痛风性关节炎116例[J];武警医学院学报;2000年04期
5 莫少庸;辨治慢性痛风性关节炎44例疗效观察[J];现代康复;2000年07期
6 包广勤,童经陆;针药加外敷治疗痛风性关节炎63例[J];现代康复;2000年09期
7 张连增,陈振伟,许正一;秦蚕汤治疗痛风性关节炎20例[J];中医药学报;2000年03期
8 兰玛;痛风汤内服配合芦荟外敷治疗痛风性关节炎36例[J];四川中医;2001年09期
9 钱轶梅,胡学文;痛风性关节炎7例误诊分析[J];西安医科大学学报;2001年01期
10 曹洪国;23例痛风性关节炎临床及误诊分析[J];现代医药卫生;2001年10期
相关会议论文 前10条
1 杨少锋;;通滞苏润江胶囊在痛风性关节炎治疗中的应用[A];全国第八届中西医结合风湿病学术会议论文汇编[C];2010年
2 刘晓玉;;痛风性关节炎病人86例的护理对策[A];重庆市中医药学会2011年学术年会论文集[C];2011年
3 任潞雪;张凤山;李英楠;王晓东;杨敏;;痛风性关节炎的误诊分析及治疗进展[A];第四届全国中西医结合风湿类疾病学术会议论文汇编[C];2000年
4 熊焰;徐萍;张育红;;28例痛风性关节炎临床分析[A];中华医学会全国风湿病学年会论文汇编[C];2003年
5 郑国伟;林奕芬;陈少如;;消痛祛风汤治疗痛风性关节炎的临床研究[A];第三届海峡两岸中西医结合学术研讨会论文集[C];2005年
6 赵爱民;栾明义;田海鑫;;中西医结合治疗痛风性关节炎[A];第十三届全国中西医结合骨伤科学术研讨会论文集[C];2005年
7 吕忠文;何颖Y,
本文编号:1593909
本文链接:https://www.wllwen.com/yixuelunwen/nfm/1593909.html